Literature DB >> 33635390

Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra.

Joseph R Berger1, Clyde Markowitz2, Peter A Merkel3,4, Rachel A Kolster5, Zissimos Mourelatos5.   

Abstract

We report a 57-year-old man with recurrent meningoencephalitis resulting in bouts of altered consciousness, encephalopathy, tremors, focal seizures, and paraparesis. The neurological manifestations were accompanied by fever and leukocytosis in the absence of other systemic manifestations. MRI abnormalities of the brain, brainstem, spinal cord and meninges and CSF pleocytosis and elevated protein were observed. Exhaustive studies failed to reveal an etiology. Brain biopsy revealed nodules of neutrophils and macrophages, but no vasculitis. The lesions were not vasocentric as would be expected with neuro-Behcet's disease and neuro-Sweet's disease. The disorder was responsive to high-dose corticosteroid therapy and, ultimately, to anakinra, an IL-1α and IL-1β receptor antagonist.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Anakinra; CNS inflammation; Meningoencephalitis; Neutrophils

Mesh:

Substances:

Year:  2021        PMID: 33635390      PMCID: PMC9394448          DOI: 10.1007/s00415-021-10431-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  10 in total

Review 1.  The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.

Authors:  Joost Frans Swart; Daantje Barug; Michelle Möhlmann; Nico M Wulffraat
Journal:  Expert Opin Biol Ther       Date:  2010-10-28       Impact factor: 4.388

2.  CNS neutrophilic vasculitis in neuro-Sweet disease.

Authors:  Robert Charlson; Ilya Kister; David Kaminetzky; Marianna Shvartsbeyn; Shane A Meehan; Irina Mikolaenko
Journal:  Neurology       Date:  2015-07-31       Impact factor: 9.910

3.  Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation.

Authors:  Yoshifumi Arai; Satoshi Kohno; Yoshitomo Takahashi; Yoshiaki Miyajima; Yoshihiro Tsutusi
Journal:  Neuropathology       Date:  2006-12       Impact factor: 1.906

4.  The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.

Authors:  Isabelle Kone-Paut; Rolando Cimaz; Jethro Herberg; Oliver Bates; Aurelia Carbasse; Jean Pierre Saulnier; Maria Cristina Maggio; Jordi Anton; Maryam Piram
Journal:  Autoimmun Rev       Date:  2018-06-06       Impact factor: 9.754

Review 5.  Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review.

Authors:  Stefanie Hennig; Keywan Bayegan; Martin Uffmann; Florian Thalhammer; Stefan Winkler
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

6.  Neuro-Behçet's disease presenting as an isolated progressive cognitive and behavioral syndrome.

Authors:  Dario Saracino; Lia Allegorico; Anna Maria Barbarulo; Bianca Pollo; Giorgio Giaccone; Alessandra D'Amico; Ludovico D'Incerti; Orso Bugiani; Giuseppe Di Iorio; Simone Sampaolo; Mariarosa Anna Beatrice Melone
Journal:  Neurocase       Date:  2018-12-25       Impact factor: 0.881

7.  The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Authors:  Alessandra Bettiol; Elena Silvestri; Gerardo Di Scala; Amedeo Amedei; Matteo Becatti; Claudia Fiorillo; Giuseppe Lopalco; Carlo Salvarani; Luca Cantarini; Alessandra Soriano; Giacomo Emmi
Journal:  Rheumatol Int       Date:  2019-02-25       Impact factor: 2.631

8.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

Authors: 
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-02-26       Impact factor: 6.166

Review 9.  Sweet's syndrome (acute febrile neutrophilic dermatosis)

Authors:  P von den Driesch
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

Review 10.  The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.

Authors:  Roberto Giacomelli; Jurgen Sota; Piero Ruscitti; Corrado Campochiaro; Serena Colafrancesco; Lorenzo Dagna; Daniela Iacono; Florenzo Iannone; Giuseppe Lopalco; Paolo Sfriso; Luca Cantarini
Journal:  Clin Exp Rheumatol       Date:  2020-05-12       Impact factor: 4.862

  10 in total
  1 in total

1.  Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications.

Authors:  Giorgio Costagliola; Greta Depietri; Alexandre Michev; Antonella Riva; Thomas Foiadelli; Salvatore Savasta; Alice Bonuccelli; Diego Peroni; Rita Consolini; Gian Luigi Marseglia; Alessandro Orsini; Pasquale Striano
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.